Case number 1:17-cv-00812
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 30, 2020 | 30 | Order (2) |
| Dec 30, 2020 | 30 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218. (Attachments: # (1) Order)(nms) |
| Dec 22, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 230 in Lead Civil Action 17-462-TBD. (nms) |
| Dec 21, 2020 | 29 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding closure of underlying cases. (Blumenfeld, Jack) |
| Dec 21, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties shall file a status letter within 7 days of the date of this Order. Ordered by Judge Richard G. Andrews on 12/21/2020. (nms) |
| Sep 28, 2018 | 27 | Order Administratively Closing Case (1) Docket Text: ORDER: The case is ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the related litigation has been resolved so this case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 9/28/2018. (nms) |
| Nov 13, 2017 | 26 | Order (7) Docket Text: SO ORDERED Granting (26 in 17-cv-1163-RGA, 28 in 17-cv-462-RGA, 27 in 17-cv-584-RGA, 23 in 17-cv-675-RGA, 29 in 17-cv-648-RGA, 24 in 17-cv-560-RGA, 29 in 17-cv-1129-RGA, 26 in 17-cv-483-RGA, 25 in 17-cv-812-RGA, 32 in 17-cv-1047-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 11/13/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Nov 10, 2017 | 25 | Stipulation (7) Docket Text: STIPULATION and [Proposed] Order of Consolidation by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Oct 24, 2017 | 24 | Order (30) Docket Text: SO ORDERED Granting Stipulated Protective Order. Signed by Judge Richard G. Andrews on 10/24/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 23, 2017 | 23 | Proposed Order (30) Docket Text: PROPOSED Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 23, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (25 in 17-cv-462-RGA, 19 in 17-cv-675-RGA, 27 in 17-cv-1047-RGA, 26 in 17-cv-648-RGA, 23 in 17-cv-1163-RGA, 22 in 17-cv-483-RGA, 22 in 17-cv-812-RGA, 24 in 17-cv-1129-RGA, 21 in 17-cv-560-RGA, 23 in 17-cv-584-RGA) Stipulation and Order on Proposed Protective Order. Signed by Judge Richard G. Andrews on 10/23/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 20, 2017 | 22 | Stipulation (6) Docket Text: STIPULATION and Order on Proposed Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 17, 2017 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Invagen Pharmaceuticals, Inc.s Rule 26 Initial Disclosures filed by InvaGen Pharmaceuticals, Inc..(Myer, R.) |
| Oct 17, 2017 | N/A | SO ORDERED (0) |
| Oct 16, 2017 | 20 | Motion for Leave to Appear Pro Hac Vice (13) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Todd L. Krause of Sidley Austin LLP - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 13, 2017 | 19 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH and Bayer AG's Initial Disclosures; and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 11, 2017 | 18 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Plaintiffs Bayer Intellectual Property GmbH, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 2, 2017 | 17 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/9/2018. Amended Pleadings due by 3/9/2018. Fact Discovery completed by 8/10/2018. Joint Claim Construction Brief due by 6/22/2018. A Markman Hearing is set for 7/3/2018, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/22/2019, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial is set for 4/1/2019, at 9:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/29/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 2, 2017 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00462-RGA et al.(cak) |
| Sep 29, 2017 | 16 | Main Document (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Smith, Rodger) Modified on 9/29/2017 (nms). |
| Sep 29, 2017 | 16 | Letter (1) |
| Sep 29, 2017 | 16 | Proposed Order (11) |
| Sep 12, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael P. Hogan for InvaGen Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Sep 11, 2017 | N/A | SO ORDERED (0) |
| Sep 11, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 9/11/2017. (Court Reporter Valerie Gunning.) Associated Cases: 1:17-cv-00462-RGA et al.(ksr, ) |
| Sep 11, 2017 | 15 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by InvaGen Pharmaceuticals, Inc.. (Myer, R.) |
| Sep 8, 2017 | N/A | SO ORDERED (0) |
| Sep 8, 2017 | 14 | Motion for Leave to Appear Pro Hac Vice (16) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, Dov P. Grossman, Alexander S. Zolan, Martha C. Kidd and Kathryn S. Kayali - filed by Bayer AG, Bayer Intellectual Property GmbH. (Smith, Rodger) |
| Sep 7, 2017 | 13 | Proposed Order (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/7/2017 (nms). |
| Sep 1, 2017 | 12 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/11/2017, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/1/2017. (nms) |
| Aug 22, 2017 | 11 | Answer to Counterclaim (17) Docket Text: ANSWER to [8] Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc..(Smith, Rodger) Modified on 8/23/2017 (nms). |
| Aug 14, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 9, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 9, 2017 | N/A | SO ORDERED (0) |
| Aug 8, 2017 | 10 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert S. Silver and Lynn M. Terrebonne - filed by InvaGen Pharmaceuticals, Inc.. (Myer, R.) |
| Aug 2, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Exhibits 1 and 2 have been added to the Answer filed at D.I. [8]. The NEF for the filing has been regenerated. (nms) |
| Aug 2, 2017 | N/A | CORRECTING ENTRY: (0) |
| Aug 2, 2017 | N/A | CORRECTING ENTRY: (0) |
| Aug 2, 2017 | N/A | CORRECTING ENTRY: (0) |
| Aug 1, 2017 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited for InvaGen Pharmaceuticals, Inc. filed by InvaGen Pharmaceuticals, Inc.. (Myer, R.) |
| Aug 1, 2017 | 8 | Exhibit 2 (11) |
| Aug 1, 2017 | 8 | Exhibit 1 (235) |
| Aug 1, 2017 | 8 | Answer to Complaint (38) |
| Aug 1, 2017 | 8 | Main Document (38) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs by InvaGen Pharmaceuticals, Inc..(Myer, R.) Modified on 8/2/2017 (nms). (Additional attachment(s) added on 8/2/2017: # (1) Exhibit 1, # (2) Exhibit 2) (nms). |
| Jul 11, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. InvaGen Pharmaceuticals, Inc. served on 7/11/2017, answer due 8/1/2017. (Fahnestock, Derek) |
| Jun 28, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 23, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to InvaGen Pharmaceuticals, Inc. on 6/23/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jun 23, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.(jcs) |
| Jun 23, 2017 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGMENENT filed against InvaGen Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2170041.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs) |
| Jun 23, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH filed by Bayer AG, Bayer Intellectual Property GMBH. (jcs) |
| Jun 23, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218. (jcs) |
| Jun 23, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 10, 2017. Date of Expiration of Patent: Feb 17, 2034.Thirty Month Stay Deadline: 1/1/2019. (jcs) |
| Jun 23, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jun 23, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 23, 2017 | 1 | Exhibit A (14) |
| Jun 23, 2017 | 1 | Complaint (10) |
| Jun 23, 2017 | 1 | Complaint* (1) |
